
Ensure is owned by Abbott Laboratories (NYSE: ABT), an American health care company headquartered in North Chicago, Illinois. Introduced in 1973 by Abbott's Ross Laboratories nutrition division, Ensure is a ready-to drink nutritional supplement sold in more than 160 countries. Abbott markets Ensure as the number one doctor recommended brand among oral nutritional products, and it anchors Abbott's adult nutrition business alongside Glucerna and ZonePerfect.
Parent Company
Founded
1973
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Ensure | Abbott Laboratories | Wholly owned |
Ensure was introduced in 1973 by Ross Laboratories, the nutrition arm of Abbott Laboratories that had joined Abbott through the 1964 merger with the Moores and Ross Milk Company. The original product was a liquid nutritional supplement positioned for hospital and clinical use, designed to provide complete balanced nutrition for patients who could not eat normally.
Through the 1980s and 1990s, Ensure expanded from clinical settings into retail as the adult nutrition category grew. The brand became a staple recommendation for older adults, patients recovering from illness or surgery, and people experiencing involuntary weight loss. Its hospital presence, where staff frequently recommended it on discharge, built a recommendation network that persists today.
The product line grew from the original ready-to-drink shake into a family of formats and formulations: Ensure Original, Ensure Plus with higher calories and protein, Ensure Max Protein, Ensure Complete, Ensure High Protein, powder versions, and clear nutrition drinks. International expansion took the brand into more than 160 countries, with particularly strong positions in Latin America, Europe, and Asia.
In the 2010s and 2020s Abbott repositioned Ensure partly toward active adults and muscle health, marketing protein content to consumers beyond the traditional elderly demographic. Competitors including Nestle's Boost and Kate Farms' plant-based products intensified competition in the adult nutrition aisle, but Ensure retained its position as the category's most recognized name.
In 2026 Abbott's Nutrition segment reported sales of $2.14 billion in Q2, with adult nutrition contributing meaningful share. Abbott's broader strategy under CEO Robert Ford has kept nutrition brands central to the consumer-facing side of a company increasingly driven by medical devices and diagnostics.
What does Abbott Laboratories own?
Abbott Laboratories owns brands across nutrition (Similac, Ensure, PediaSure, Pedialyte), medical devices (FreeStyle Libre, Volt, TactiFlex, Amulet), and diagnostics (Cologuard, BinaxNOW, Alinity). The company acquired Exact Sciences in March 2026 for $21 billion, adding Cologuard and other molecular diagnostic products.
Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories trades on the New York Stock Exchange under the ticker symbol ABT. The company has been publicly listed since 1929 and is a component of the S&P 500 Index.
Who founded Abbott Laboratories?
Abbott was founded in 1888 by Dr. Wallace Calvin Abbott, a physician in Ravenswood, Illinois (now part of Chicago). He began by manufacturing reliable dosimetric granules for pharmaceutical use.
Where is Abbott Laboratories headquartered?
Abbott is headquartered in Abbott Park, North Chicago, Illinois, USA. The company operates in more than 160 countries globally.
How many brands does Abbott Laboratories own?
Abbott owns numerous brands across its four segments. Key consumer brands include Similac, Ensure, PediaSure, and Pedialyte in nutrition. Key medical device brands include FreeStyle Libre, Volt, and Amulet. Key diagnostics brands include Cologuard, BinaxNOW, and Alinity.
Who owns Abbott Laboratories?
Abbott Laboratories is a publicly traded company with shares held by institutional investors, mutual funds, and individual shareholders. The company is led by Chairman and CEO Robert B. Ford.
What is Abbott Laboratories' revenue?
Abbott reported Q2 2026 sales of $12.59 billion, up 13.0% on a reported basis and 4.8% on a comparable basis. The company reaffirmed full-year 2026 comparable sales growth guidance of 6.5% to 7.5% and raised adjusted diluted EPS guidance to $5.45 to $5.60.
Did Abbott acquire Exact Sciences?
Yes, Abbott completed the $21 billion acquisition of Exact Sciences in March 2026. The acquisition added Cologuard, a noninvasive colorectal cancer screening test, to Abbott's diagnostics portfolio. Diagnostics sales grew 42% year over year in Q2 2026, the first full quarter including Exact Sciences results.
Abbott has committed to science-based emissions reduction targets covering Scope 1, 2, and 3 emissions and has invested in packaging improvements across its nutrition brands, including efforts to reduce single-use plastic.
Ensure is not certified organic or plant-based in its standard formulations; the product is dairy-protein based. Abbott publishes an annual sustainability report covering its nutrition supply chain, though independent certifications specific to the Ensure brand are not held. The company is not a Certified B Corporation.
Abbott states that it complies with local marketing regulations for nutritional products in all markets. Infant formula marketing at the corporate level has drawn scrutiny from advocacy groups, though that issue concerns the Similac line rather than Ensure.
2022 Abbott nutrition recall impact: Abbott's voluntary recall of powdered formulas manufactured at its Sturgis, Michigan facility in February 2022 primarily affected Similac and specialty products. Ensure was not among the recalled formulas, but the event subjected Abbott's nutrition manufacturing to heightened FDA attention and damaged consumer trust across the division.
Marketing scrutiny: Nutrition industry marketing practices, including health claims on supplemental drinks, are reviewed periodically by regulators. Abbott has faced criticism over the years from consumer advocates regarding the positioning of nutritional drinks relative to whole food, though no major regulatory action has resulted for the Ensure brand specifically.
General product complaints: As with any mass food product, the brand has had isolated quality complaints and minor labeling adjustments over the years, none resulting in a major standalone Ensure recall.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Abbott Laboratories | USA | 1964 | Mass market | United states | All-ages | |
| Abbott Laboratories | USA | 1988 | Mass market | Global | All-ages | |
| Coca Cola Company | USA | 1996 | Mass market | Global | All-ages | |
| Abbott Laboratories | USA | 2003 | Premium | United states | All-ages |
Healthcare PharmaceuticalsOwned by Abbott Laboratories
Oral electrolyte solution brand owned by Abbott Laboratories, first issued to hospitals in 1966 and now marketed to children and adults for hydration.
Baby CareOwned by Abbott Laboratories
Children's nutritional supplement drink brand owned by Abbott Laboratories, launched in 1988 and marketed for children ages 1 to 13 needing supplemental nutrition.
Food BeverageOwned by The Coca-Cola Company
American enhanced water brand featuring vapor-distilled water with added vitamins, minerals, and natural flavors, known for its colorful packaging and health-focused positioning.
Baby CareOwned by Abbott Laboratories
Amino acid-based hypoallergenic infant and child formula brand owned by Abbott Laboratories, launched in 2003 for severe protein allergies and manufactured at Abbott's Sturgis, Michigan facility.
Market Positioning: Ensure competes with 4 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Abbott Laboratories, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike Ensure which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike Ensure which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Ensure which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike Ensure which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Ensure which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.